Outbreak of Candida albicans fungaemia in a neonatal intensive care unit

Yhu Chering Huang, Tzou Yien Lin, Hwei Ling Peng, June Hsieh Wu, Hwan You Chang, Hsieh Shong Leu

Research output: Contribution to journalArticle

47 Citations (Scopus)

Abstract

During a 4-month period, 9 premature infants hospitalized in a neonatal intensive care unit (NICU) developed Candida albicans fungaemia. All 9 infants received antifungal agents. Fluconazole was administered in 7 patients and successfully eradicated this organism in 6 with no adverse effects. For epidemiological investigation, 64 environmental specimens and hand-washings of all 54 staff members involved in the NICU mere examined for the presence of this organism. No C. albicans could be identified from environmental sources, while the hand-mashing of 1 nurse was C. albicans-positive. Two genotyping methods, including electrophoretic karyotyping using contour-clamped homogeneous electric field gel electrophoresis and polymerase chain reaction-based direct sequencing of rRNA gene, were used in the analysis of the isolates recovered from blood cultures of the infants, the hand-mashing of the nurse and 7 control isolates. Both methods yielded comparable results and revealed that all 13 isolates from infected infants as well as the isolate from hand washing of the nurse were of the same genotype while the control isolates were distinct. These results suggest that the outbreak of C, albicans fungaemia was caused by a particular strain and possibly via cross-infection. In addition, we showed that fluconazole seemed to be safe and effective in treating C. albicans fungaemia in neonates, although the data were limited.

Original languageEnglish
Pages (from-to)137-142
Number of pages6
JournalScandinavian Journal of Infectious Diseases
Volume30
Issue number2
Publication statusPublished - 1998
Externally publishedYes

Fingerprint

Fungemia
Neonatal Intensive Care Units
Candida albicans
Disease Outbreaks
Hand Disinfection
Fluconazole
Nurses
Hand
Karyotyping
Antifungal Agents
Pulsed Field Gel Electrophoresis
Cross Infection
rRNA Genes
Premature Infants
Genotype
Newborn Infant
Polymerase Chain Reaction

ASJC Scopus subject areas

  • Microbiology (medical)
  • Immunology

Cite this

Huang, Y. C., Lin, T. Y., Peng, H. L., Wu, J. H., Chang, H. Y., & Leu, H. S. (1998). Outbreak of Candida albicans fungaemia in a neonatal intensive care unit. Scandinavian Journal of Infectious Diseases, 30(2), 137-142.

Outbreak of Candida albicans fungaemia in a neonatal intensive care unit. / Huang, Yhu Chering; Lin, Tzou Yien; Peng, Hwei Ling; Wu, June Hsieh; Chang, Hwan You; Leu, Hsieh Shong.

In: Scandinavian Journal of Infectious Diseases, Vol. 30, No. 2, 1998, p. 137-142.

Research output: Contribution to journalArticle

Huang, YC, Lin, TY, Peng, HL, Wu, JH, Chang, HY & Leu, HS 1998, 'Outbreak of Candida albicans fungaemia in a neonatal intensive care unit', Scandinavian Journal of Infectious Diseases, vol. 30, no. 2, pp. 137-142.
Huang, Yhu Chering ; Lin, Tzou Yien ; Peng, Hwei Ling ; Wu, June Hsieh ; Chang, Hwan You ; Leu, Hsieh Shong. / Outbreak of Candida albicans fungaemia in a neonatal intensive care unit. In: Scandinavian Journal of Infectious Diseases. 1998 ; Vol. 30, No. 2. pp. 137-142.
@article{fd6651a1335c4f3f97f94df1364caa5c,
title = "Outbreak of Candida albicans fungaemia in a neonatal intensive care unit",
abstract = "During a 4-month period, 9 premature infants hospitalized in a neonatal intensive care unit (NICU) developed Candida albicans fungaemia. All 9 infants received antifungal agents. Fluconazole was administered in 7 patients and successfully eradicated this organism in 6 with no adverse effects. For epidemiological investigation, 64 environmental specimens and hand-washings of all 54 staff members involved in the NICU mere examined for the presence of this organism. No C. albicans could be identified from environmental sources, while the hand-mashing of 1 nurse was C. albicans-positive. Two genotyping methods, including electrophoretic karyotyping using contour-clamped homogeneous electric field gel electrophoresis and polymerase chain reaction-based direct sequencing of rRNA gene, were used in the analysis of the isolates recovered from blood cultures of the infants, the hand-mashing of the nurse and 7 control isolates. Both methods yielded comparable results and revealed that all 13 isolates from infected infants as well as the isolate from hand washing of the nurse were of the same genotype while the control isolates were distinct. These results suggest that the outbreak of C, albicans fungaemia was caused by a particular strain and possibly via cross-infection. In addition, we showed that fluconazole seemed to be safe and effective in treating C. albicans fungaemia in neonates, although the data were limited.",
author = "Huang, {Yhu Chering} and Lin, {Tzou Yien} and Peng, {Hwei Ling} and Wu, {June Hsieh} and Chang, {Hwan You} and Leu, {Hsieh Shong}",
year = "1998",
language = "English",
volume = "30",
pages = "137--142",
journal = "Infectious Diseases",
issn = "2374-4235",
publisher = "Taylor and Francis Ltd.",
number = "2",

}

TY - JOUR

T1 - Outbreak of Candida albicans fungaemia in a neonatal intensive care unit

AU - Huang, Yhu Chering

AU - Lin, Tzou Yien

AU - Peng, Hwei Ling

AU - Wu, June Hsieh

AU - Chang, Hwan You

AU - Leu, Hsieh Shong

PY - 1998

Y1 - 1998

N2 - During a 4-month period, 9 premature infants hospitalized in a neonatal intensive care unit (NICU) developed Candida albicans fungaemia. All 9 infants received antifungal agents. Fluconazole was administered in 7 patients and successfully eradicated this organism in 6 with no adverse effects. For epidemiological investigation, 64 environmental specimens and hand-washings of all 54 staff members involved in the NICU mere examined for the presence of this organism. No C. albicans could be identified from environmental sources, while the hand-mashing of 1 nurse was C. albicans-positive. Two genotyping methods, including electrophoretic karyotyping using contour-clamped homogeneous electric field gel electrophoresis and polymerase chain reaction-based direct sequencing of rRNA gene, were used in the analysis of the isolates recovered from blood cultures of the infants, the hand-mashing of the nurse and 7 control isolates. Both methods yielded comparable results and revealed that all 13 isolates from infected infants as well as the isolate from hand washing of the nurse were of the same genotype while the control isolates were distinct. These results suggest that the outbreak of C, albicans fungaemia was caused by a particular strain and possibly via cross-infection. In addition, we showed that fluconazole seemed to be safe and effective in treating C. albicans fungaemia in neonates, although the data were limited.

AB - During a 4-month period, 9 premature infants hospitalized in a neonatal intensive care unit (NICU) developed Candida albicans fungaemia. All 9 infants received antifungal agents. Fluconazole was administered in 7 patients and successfully eradicated this organism in 6 with no adverse effects. For epidemiological investigation, 64 environmental specimens and hand-washings of all 54 staff members involved in the NICU mere examined for the presence of this organism. No C. albicans could be identified from environmental sources, while the hand-mashing of 1 nurse was C. albicans-positive. Two genotyping methods, including electrophoretic karyotyping using contour-clamped homogeneous electric field gel electrophoresis and polymerase chain reaction-based direct sequencing of rRNA gene, were used in the analysis of the isolates recovered from blood cultures of the infants, the hand-mashing of the nurse and 7 control isolates. Both methods yielded comparable results and revealed that all 13 isolates from infected infants as well as the isolate from hand washing of the nurse were of the same genotype while the control isolates were distinct. These results suggest that the outbreak of C, albicans fungaemia was caused by a particular strain and possibly via cross-infection. In addition, we showed that fluconazole seemed to be safe and effective in treating C. albicans fungaemia in neonates, although the data were limited.

UR - http://www.scopus.com/inward/record.url?scp=0031812265&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0031812265&partnerID=8YFLogxK

M3 - Article

C2 - 9730299

AN - SCOPUS:0031812265

VL - 30

SP - 137

EP - 142

JO - Infectious Diseases

JF - Infectious Diseases

SN - 2374-4235

IS - 2

ER -